Welcome to ASCO’s Press Center. Find the latest news releases related to ASCO’s peer-reviewed journals, scientific meetings, and public policy-related statements and initiatives, as well as ...
Our grants and awards support basic, translational and clinical cancer research done by gifted physician-scientists at every stage of their careers, from the best and brightest among young ...
This page contains important information for corporate and institutional public relations professionals about ASCO Meetings. Once an abstract is submitted to an ASCO Meeting, the abstract and study ...
The American Society of Clinical Oncology (ASCO) is a professional oncology society committed to conquering cancer through research, education, prevention, and the delivery of high-quality patient ...
Conquering cancer through research, education, and promotion of the highest quality patient care. ASCO is supported by its affiliate organization, Conquer Cancer, the ASCO Foundation, which funds ...
Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.
What is Off-Label Use? A doctor can prescribe a US Food and Drug Administration (FDA) approved medication that is not yet approved to treat the specific type of cancer a person has. This is called ...
The Conquer Cancer Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this award is to fund ...
The Association for Clinical Oncology is a 501(c)(6) organization established by the American Society of Clinical Oncology that works to ensure all individuals with cancer have access to high-quality, ...
The Association for Clinical Oncology (ASCO) offers multiple ways for you and your colleagues to engage with policymakers and educate them on ASCO’s advocacy priorities, while leveraging your insights ...
To improve patient care, ASCO advocates for increased federal funding for research, greater health care access, value in cancer care, and payment reform.